CLRB Competitors & Alternatives
Compare Cellectar Biosciences Inc with similar stocks in the same industry
Biotechnology
CLRB
Main Stock$2.63
Tradestie Score
49
Market Cap
$18.42M
Analyst Upside
+292.9%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.44
|
$154.27M | - | 52 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.21
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.43
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$28.03
|
$110.20M | - | 63 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.45
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.52
|
$67.94M | - | 61 | Compare |
|
MBRX
Moleculin Biotech, Inc.
|
$2.21
|
$26.23M | - | 51 | Compare |
|
PULM
Pulmatrix, Inc. Common Stock
|
$1.67
|
$17.88M | - | 57 | Compare |
|
BLRX
BioLineRX Ltd
|
$3.10
|
$16.50M | - | 56 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
More CLRB Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry